Lawyers targeted for allegedly unethical actions. Maybe the

New Post Public Reply Private Reply Replies (0) Message Board
Drano
Lawyers targeted for allegedly unethical actions. Maybe the tide is beginning to turn and lawyers will no longer be invulnerable

Quote:
LAWYERS IN LINE OF FIRE AT DELAWARE COURTS First investment banks came under fire for the roles they played in billion-dollar buyouts, and now there is a case that could extend liability to the lawyers in buyouts, Steven Davidoff Solomon writes in Deal Professor.

The complaint arose from the $2.2 billion buyout of the ExamWorks Group, which contends that lawyers at Paul Hastings, a law firm in Los Angeles, were in cahoots with management and the investment banks to sell the company at a below-market price. ExamWorks, a medical examination company, vigorously denies this.

Daytona Beach Police and Fire Pension Fund, a shareholder of ExamWorks, is suing the company's directors, as well as the private equity firm leading the buyout, Leonard Green & Partners. It says Paul Hastings failed to run the process appropriately.

Management and directors were participating in the buyout. Companies usually establish a committee of independent directors to guide the process from the beginning, but ExamWorks was slow to do this.

The board still included management in the buyout discussions and even after the founders were excluded from the special committee, they appear to have regularly participated in meetings.

At the same time, Reinaldo Pascual, a partner at Paul Hastings, continued to represent the board while representing management in negotiating the buyout arrangements. He also represented the special committee and the company itself.

The lawsuit contends that the special committee failed to bargain effectively, negotiating an increase of 5 cents from the top of the firm's indicated range, and no competing bids emerged during the short 25-day "go shop" period, although some private equity firms expressed interest.

The price being paid is below ExamWorks' 52-week stock market high of $44.09 and only a 4 percent premium over the closing price the day before the deal announcement, albeit 37 percent over the price when Leonard Green's first bid came in.

In the past, when there were questions about how a sale was run, lawyers were largely out of the line of fire. But this case threatens to open the floodgates and expose lawyers to the same type of conflict liability and heat that investment bankers are under. Paul Hastings is not a defendant, but the complaint indicates that it may become one.


This is from a NY Times daily email, "Deal Professor" is where you can find the original on the NYTimes website.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading